In the News

Read the latest about us

LaBiotech interview with Modus

Learn more about our study in the Middle East.

Innovative Bahraini Deal Inked For Sickle Cell Therapy

Modus Therapeutics AB announced Feb. 16, the Middle East University has shouldered some of the risk of developing sevuparin.